跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
赛美维 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Ganciclovir for Injection
Approved
化学药品
Ganciclovir for Injection
Cheplapharm Arzneimittel Gmbh
🇨🇳 National Medical Products Administration
Approval Date
Oct 10, 2023
Approval ID
8VIZFKIL8Sf
Company
Cheplapharm Arzneimittel Gmbh
Type
化学药品
Approval Details
Approval Id
8VIZFKIL8Sf
Approval Number
国药准字HJ20130374
Generic Name
注射用更昔洛韦
Generic Name En
Ganciclovir for Injection
Trade Name
赛美维
Drug Type
化学药品
Dosage Form
注射剂
Strength
0.5克
Reg Date
2023-10-10
Expired Date
2028-10-09
Company Name
Cheplapharm Arzneimittel Gmbh
Production Company Name
BSP PHARMACEUTICALS SPA
Company Detail Path
/organization/cheplapharm-arzneimittel-gmbh
Production Company Detail Path
/organization/bsp-pharmaceuticals-spa
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Oct 10, 2023
Approval ID
8VIZFKIL8Sf
Type
化学药品
Back to NMPA Approvals